Elisenda Vall, Vicente Araya, Lidia Tortajada, Vanessa Escobedo, Rosa Nogueiras, Javier Del Riego
{"title":"Idiopathic granulomatous mastitis after mRNA vaccination against COVID-19: a possible association?","authors":"Elisenda Vall, Vicente Araya, Lidia Tortajada, Vanessa Escobedo, Rosa Nogueiras, Javier Del Riego","doi":"10.1093/bjrcr/uaae048","DOIUrl":null,"url":null,"abstract":"<p><p>Idiopathic granulomatous mastitis (IGM) is an uncommon benign disease thought to have an autoimmune origin. After massive vaccination against COVID-19, mRNA vaccines have been associated with various possible adverse effects. Among those involving the breast, the most common are ipsilateral axillary lymphadenopathies and transient breast oedema. We present the case of a young woman who developed IGM after mRNA vaccination against COVID-19. We describe the clinical and imaging findings and management of this case, discussing the evidence for a possible link between vaccination and the development of this uncommon inflammatory process and underlining the importance of including this entity in the differential diagnosis in this scenario.</p>","PeriodicalId":45216,"journal":{"name":"BJR Case Reports","volume":"11 1","pages":"uaae048"},"PeriodicalIF":0.5000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849954/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJR Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjrcr/uaae048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Idiopathic granulomatous mastitis (IGM) is an uncommon benign disease thought to have an autoimmune origin. After massive vaccination against COVID-19, mRNA vaccines have been associated with various possible adverse effects. Among those involving the breast, the most common are ipsilateral axillary lymphadenopathies and transient breast oedema. We present the case of a young woman who developed IGM after mRNA vaccination against COVID-19. We describe the clinical and imaging findings and management of this case, discussing the evidence for a possible link between vaccination and the development of this uncommon inflammatory process and underlining the importance of including this entity in the differential diagnosis in this scenario.